Erdal, M. A. Et Al. 2025. Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye. Turkish Journal of Pediatrics , vol.67, no.1 , 22-30.

Erdal, M. A., Büyükşahin, H. N., Şen, V., KILINÇ SAKALLI, A. A., Çokuğraş, H., Doğan, G., ... Yılmaz, A. İ.(2025). Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye. Turkish Journal of Pediatrics , vol.67, no.1, 22-30.

Erdal, Meltem Et Al. "Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye," Turkish Journal of Pediatrics , vol.67, no.1, 22-30, 2025

Erdal, Meltem A. Et Al. "Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye." Turkish Journal of Pediatrics , vol.67, no.1, pp.22-30, 2025

Erdal, M. A. Et Al. (2025) . "Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye." Turkish Journal of Pediatrics , vol.67, no.1, pp.22-30.

@article{article, author={Meltem Akgül Erdal Et Al. }, title={Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye}, journal={Turkish Journal of Pediatrics}, year=2025, pages={22-30} }